Trump Proposes 100% Tariff on Imported Generic Drugs
Former President Trump announced plans to impose a 100 percent tariff on imported generic drugs starting in August 2028. This measure, aimed at encouraging the reshoring of pharmaceutical production to the United States, would penalize companies that do not move…
Miami Fort Lauderdale, FL, July 22, 2026 —
Former President Donald Trump has announced a proposal to implement a 100 percent tariff on imported generic drugs, with a planned start date of August 2028.
The objective behind this proposed tariff is to incentivize the relocation of pharmaceutical manufacturing facilities back to the United States. This initiative aims to penalize companies that continue to source their generic drug production from overseas, encouraging them to move their operations to U.S. soil.
The proposed measure targets imported generic drugs specifically. The timeline for this potential policy change is set to begin in August 2028.
Details regarding the specific mechanisms for identifying and penalizing companies that do not reshore their manufacturing operations were not provided. The announcement did not include information on potential exemptions or specific timelines for compliance beyond the August 2028 start date.
Story summarized from the original created by Nathaniel Weixel on thehill.com, see more information here.
Media gallery